A novel pre-B acute lymphoblastic leukemia cell line with chromosomal translocation between p16(INK4A)/p15(INK4B) tumor suppressor and immunoglobulin heavy chain genes: TGFβ/IL-7 inhibitory signaling mechanism

Leukemia

Volumn 10, Issue 10, 1996, Pages 1576-1583

  Urashima, M ^a   Hoshi, Y ^b   Sugimoto, Y ^c   Kaihara, C ^d   Matsuzaki, M ^d   Chauhan, D ^a   Ogata, A ^a   Teoh, G ^a   DeCaprio, J A ^a,e   Anderson, K C ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Ctr Molec Biol Cytogenet S   (Japan)

^d SRL INC   (Japan)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Chromosomal translocation; Interleukin 7; p16; Pre B ALL; Transforming growth factor

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLINE; IMMUNOGLOBULIN HEAVY CHAIN; INTERLEUKIN 7; PROTEIN KINASE INHIBITOR; PROTEIN P21; RETINOBLASTOMA PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CASE REPORT; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMOSOME 14Q; CHROMOSOME 9P; CHROMOSOME TRANSLOCATION; COMPLEX FORMATION; FEMALE; GENE DELETION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOGLOBULIN GENE; LEUKEMIA CELL LINE; POLYMERASE CHAIN REACTION; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

EID: 10144232759     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Hirama T, Koeffler HP. Role of cyclin-dependent kinase inhibitors in the development of cancer. Blood 1995; 86: 841-854.
2. DeCaprio JA, Ludlow JW, Lynch D, Furukawa Y, Griffin J, Piwnica-Worms H, Huang C-M, Livingston DW. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 1989; 58: 1085-1095.
3. Mittnacht S, Weinberg RA. G1/S phosphorylation of the retinoblastoma protein is associated with an altered affinity for the nuclear compartment. Cell 1991; 65: 381-393.
4. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995; 81: 323-330.
5. Chellappan SP, Hiebert S, Mudryi M, Horowitz JM, Nevins JR. The E2F transcription factor is a cellular target for the RB protein. Cell 1991; 65: 1053-1061.
6. LaThangue NB. DRTF1/E2F: an expanding family of heterodimeric transcription factors implicated in cell-cycle control. Trends Biochem Sci 1994; 19: 108-114.
7. Ewen ME, Sluss HK, Sherr CJ, Matsushime H, Kato JY, Livingston DM. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 1993; 73: 487-497.
8. Kato J-Y, Matsushime H, Hiebert SW, Ewen ME, Sherr CJ. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev 1993; 7: 331-342.
9. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993; 366: 704-707.
10. INK4/MTS1 tumor suppressor gene product. EMBO J 1995; 14: 503-511.
11. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 1994; 368: 753-756.
12. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day III RS, Johnson BE, Skolnick MH. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994; 264: 436-440.
13. INK4 in human cancer. Proc Natl Acad Sci USA 1994; 91: 11045-11049.
14. Caldas C, Hahn SA, daCosta LT, Redston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH, Yeo CJ, Kern S. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet 1994; 8: 27-32.
15. Hussussian CJ, Struewing JP, Goldstein AM, Higgins PAT, Ally DS, Sheahan MD, Clark Jr WH, Tucker MA, Dracopoli NC. Germline p16 mutations in familial melanoma. Nat Genet 1994; 8: 15-21.
16. Ogawa S, Hirano N, Sato N, Takahashi T, Hangaishi A, Tanaka K, Kurokawa M, Tanaka T, Mitani K, Yazaki Y, Hirai H. Homozygous loss of the cyclin-dependent kinase 4-inhibitor (p16) gene in human leukemias. Blood 1994; 84: 2431-2435.
17. INK4 gene inactivation in acute lymphoblastic leukemia. Blood 1995; 85: 3431-3436.
18. INK4B gene deletions in primary leukemias. Blood 1995; 86: 311-315.
19. Dreyling MH, Bohlander SK, LeBeau MM, Olopade OI. Refined mapping of genomic rearrangement involving the short arm of chromosome 9 in acute lymphoblastic leukemias and other hematologic malignancies. Blood 1995; 86: 1931-1938.
20. Fizzotti M, Cimino G, Pisegna S, Alimena G, Quartnarone C, Mandelli F, Pelicci PG, Coco FL. Detection of homozygous deletions of the cyclin-dependent kinase 4 inhibitor (p16) gene in acute lymphoblastic leukemia and association with adverse prognostic features. Blood 1995; 85: 2685-2690.
21. Takeuchi S, Bartram CR, Seriu T, Miller CW, Tobles A, Janssen WG, Reiter A, Ludwig W-D, Zimmermann M, Schwaller J, Lee E, Miyoshi I, Koeffler PH. Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood. Blood 1995; 86: 755-760.
22. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D. 5′ CpG island methylation is associated with transcriptional silencing on the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nature Med 1995; 1: 686-696.
23. INK4B1. Cancer Res 1996; 722-727.
24. Shapiro GI, Park JE, Edwards CD, Maoi L, Merlos A, Sidransky D, Ewen ME, Rollins BJ. Multiple mechanisms of p16INK4A inactivation in non-small lung cancer cell lines. Cancer Res 1995; 55: 6200-6209.
25. Duro D, Bernard O, Delia Valle V, Berger R, Larsen C-J. A new type of p16INK4/MTS1 gene transcript expressed in B cell malignancies. Oncogene 1995; 11: 21-29.
26. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 1994; 371: 257-260.
27. Urashima M, Chauhan D, Hatzianni M, Ogata A, Hollenbaugh D, Aruffo A, Anderson KC. CD40 ligand triggers interleukin-6-mediated B cell differentiation. Leukemia Res (in press).
28. Popp S, Jauch A, Qui YJ, Smialek B, Cremer T, Becher R. Translocation (8;21) in acute nonlymphocytic leukemia delineated by chromosomal in situ suppression hybridization. Cancer Genet Cytogenet 1991; 57: 103-106.
29. Foon AK, Todd RF. Immunologic classification of leukemia and lymphoma. Blood 1986; 68: 1-31.
30. Aizawa S, Yaguchi M, Nakao M, Toyama K, Inokuchi S, Imai T, Uasuda M, Nabeshima R, Hanada H. Hematopoietic supportive function of human bone marrow stromal cell lines established by a recombinant SV40-adenovirus vector. Exp Hematol 1994; 22: 482-486.
31. Urashima M, Hasegawa N, Kamijo M, Shishikura A, Kato Y, Hoshi Y, Akatsuka J-I, Maekawa K. Establishment of human pro-B cell line (JKB-1) and its differentiation on pre-established bone marrow stromal cell layer. Am J Hematol 1994; 46: 112-119.
32. Urashima M, Chauhan D, Uchiyama H, Freeman GJ, Anderson KC. CD40 ligand triggered interleukin-6 secretion in multiple myeloma. Blood 1995; 85: 1903-1912.
33. Urashima M, Ogata A, Chauhan D, Hatziyanni M, Vidriales MB, Dedera DA, Schlossman RL, Anderson KC. Transforming growth factor β1: differential effects on multiple myeloma versus normal B cells. Blood 1996; 87: 1928-1938.
34. Wang JYJ, Knudsen ES, Welch PKJ. The retinoblastoma tumor suppressor protein. Adv Cancer Res 1994; 64: 25-85.
35. Jen J, Wade Harper J, Binger SH, Binger DD, Papadopoulos N, Markowitz S, Willson JKV, Kinzler KW, Vogelstein B. Deletion of p16 and p15 genes in brain tumors. Cancer Res 1994; 54: 6353-6358.
36. Leder P, Battey J, Lenoir G, Moulding C, Murphy W, Dotten H, Stewart T, Taub R. Translocations among antibody genes in human cancer. Science 1983; 222: 1435-1438.
37. Cleary ML, Smith SD, Sklar J. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell 1986; 47: 19-28.
38. Molot RJ, Meeker TC, Wittwer CT, Perkins SL, Segal GH, Masih AS, Braylan RC, Kjeldsberg CR. Antigen expression and polymerase chain reaction amplification of mantle cell lymphomas. Blood 1994; 83: 1626-1631.
39. Rimokh R, Berger F, Deisol G, Digonnet I, Rouault JP, Tigaud JD, Gadoux M, Coiffier B, Bryon PA, Magaud JP. Detection of the chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell lymphomas. Blood 1994; 83: 1871-1875.
40. Ye BH, Rao PH, Chaganti RSK, Dalla-Favera R. Cloning of bcl-6, the locus involved in chromosome translocations affecting band 3q27 in B-cell lymphoma. Cancer Res 1993; 53: 2732-2735.
41. Ye BH, Lista F, LoCoco F, Knowles DM, Offit K, Chagani RSK, Dalla-Favera R. Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science 1993; 262: 747-750.
42. INK4/MTS1 gene by a chromosomal translocation t(9;14)(p21-22;q11) in an acute lymphoblastic leukemia of B-cell type. Cancer Res 1996; 56: 848-854.
43. Ewen ME, Sluss HK, Whitehouse LL, Livingston DM. TGFβ inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell 1993; 74: 1009-1020.
44. Ewen ME, Oliver CJ, Sluss HK, Miller SJ, Peeper DA. p53-dependent repression of CDK4 translation in TGF-β-induced G1 cell-cycle arrest. Genes Dev 1995; 9: 204-217.
45. Reynisdottir I, Polyak K, Iavarone A, Massague J. Kip/cip and ink4 cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev 1995; 9: 1831-1845.
46. Wolf ML, Weng W-K, Stieglbauer KT, Shah N, LeBien TW. Functional effect of IL-7-enhanced CD19 expression on human B cell precursors. J Immunol 1993; 151: 138-148.
47. Villabianca JG, Anderson JM, Moseley M, Law C-L, Elstrom RL, LeBien TW. Differentiation of normal human pre-B cells in vitro. J Exp Med 1990; 172: 325-334.
48. Skjonsberg C, Frikstein BK, Saeland EB, Lie SO, Funderud S, Beiske K, Blomhoff HK. Interleukin-7 differentiates a subgroup of acute lymphoblastic leukemias. Blood 1991; 77: 2445-2450.
49. Pandrau-Garcia D, Saint-Vis B, Saeland S, Renard N, Ho S, Moreat I, Banchereau J, Galizzi J-P. Growth inhibitory and agonistic signals of IL-7 can be mediated through the CDw127 IL-7 receptor. Blood 1994; 83: 3613-3619.